NeuroOne Medical Technologies Corp filed an amendment to its previous report to include details about the 2025 Equity Incentive Plan approved by stockholders on February 14, 2025, which allows for the issuance of up to 3,000,000 shares. The plan includes various stock awards for employees and directors, and the amendment also restates prior voting results from the annual meeting.